Restored cardiac conditions and left ventricular function after parathyroidectomy in a hemodialysis patient parathyroidectomy improves cardiac fatty acid metabolism assessed by 123I-BMIPP

Circulation Journal

Volumn 73, Issue 10, 2009, Pages 1956-1960

  Nanasato, Mamoru ^a   Goto, Norihiko ^a   Isobe, Satoshi ^b   Unno, Kazumasa ^c   Hirayama, Haruo ^a   Sato, Tetsuhiko ^a   Matsuoka, Susumu ^a   Nagasaka, Takaharu ^a   Tominaga, Yoshihiro ^a   Uchida, Kazuharu ^a   Murohara, Toyoaki ^c  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b Kami iida Daiichi General Hospital   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Hemodialysis; Left ventricular function; Parathyroidectomy; Scintigraphy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; BRAIN NATRIURETIC PEPTIDE; FATTY ACID; PARATHYROID HORMONE;

ADULT; ANEMIA; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CLINICAL FEATURE; DRUG UPTAKE; FATTY ACID METABOLISM; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE METABOLISM; HEMODIALYSIS; HUMAN; IMAGE ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; SECONDARY HYPERPARATHYROIDISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FATTY ACIDS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; IODINE RADIOISOTOPES; IODOBENZENES; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PARATHYROID HORMONE; PARATHYROIDECTOMY; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; RENAL DIALYSIS; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 70349866213     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0415     Document Type: Article

References (27)

1. Drueke T, Fauchet M, Fleury I, Lesourd P, Toure Y, Le Pailleur C, et al. Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lance: 1980; 1: 112-114. (Pubitemid 10193044)
2. Bogin E, Levi I, Harary I, Massry SG. Effects of parathyroid hormone on oxidative phosphorylation of heart mitochondria. Miner Electrolyte Metab 1982; 7: 151-156.
3. Baczynski R, Massry SG, Kohan R, Magott M, Saglikes Y, Brautbar N. Effect of parathyroid hormone on myocardial energy metabolism in the rat Kidney Int 1985; 27: 718-725.
4. Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-1819. (Pubitemid 24976985)
5. Goto N, Tominaga Y, Matsuoka S, Sato I, Katayama A, Haba I, et al. Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy. Clin Exp Nephrol 2005; 9: 138-141. (Pubitemid 40875103)
6. Nagashima M, Hashimoto K, Shinsato T, Ashida K, Kobayashi M, Yamashita H, et al. Marked improvement of left ventricular function after parathyroidectomy in a hemodialysis patient with secondary hyperparathyroidism and left ventricular dysfunction. Circ J 2003; 67: 269-272. (Pubitemid 36362506)
7. Zammit VA. Carnitine acyltransferases: Functional significance of subcellular distribution and membrane topology. Prog Lipid Res 1999; 38: 199-224.
8. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213: 263-276. (Pubitemid 24262910)
9. Smogorzewski M, Perna AF, Borum PR, Massry SG. Fatty acid oxidation in the myocardium: Effects of parathyroid hormone and CRF. Kidney In: 1988; 34: 797-803. (Pubitemid 19001697)
10. London GM, Parfrey PS. Cardiac disease in chronic uremia: Pathogenesis. Adv Ren Replace Ther 1997; 4: 194-211. (Pubitemid 27304995)
11. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon I, Port FK. Association of elevated serum PO(4), CaxPO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
12. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006; 113: 266-272. (Pubitemid 43754384)
13. Bogin E, Massry SG, Harary I. Effect of parathyroid hormone on rat heart cells. J Clin Invest 1981; 67: 1215-1227. (Pubitemid 11090564)
14. Torizuka K, Yonekura Y, Nishimura T, Ohtake T, Bunko H, Tamaki N, et al. Phase 3 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism: A multi-center trial. Kaku Igaku 1992; 29: 413-433.
15. Abe M, Joh T, Hara Y, Hashida K, Koyama Y, Kazatani Y. Evaluation of myocardial damage using 123I-BMIPP imaging in patients with vasospastic angina. Kaku Igaku 1996; 33: 599-606.
16. Yoshinaga K, Tahara M, Torii H, Kihara K. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy. Ann Nucl Med 1998; 12: 341-347. (Pubitemid 29078772)
17. Yamamichi Y, Kusuoka H, Morishita K, Shirakami Y, Kurami M, Okano K, et al. Metabolism of iodine- 123-BMIPP in perfused rat hearts. J Nucl Med 1995; 36: 1043-1050.
18. Yamauchi S, Takeishi Y, Minamihaba O, Arimoto T, Hirono O, Takahashi H, et al. Angiotensin-Converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure. Nucl Med Commun 2003; 24: 901-906.
19. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998; 83: 969-979. (Pubitemid 28520926)
20. De Geeter F, Caveliers V, Pansar I, Bossuyt A, Franken PR. Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers. J Nucl Med 1998; 39: 1850-1856. (Pubitemid 28518880)
21. Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hata T, et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: Implications for clinical SPECT. J Nucl Med 1997; 38: 1857-1863. (Pubitemid 28030911)
22. 123I-15-(p-iodophenyl)-3-R,S-methyl pentadecanoic acid myocardial single photon emission computed tomography in a 55-year-old woman. Jpn Circ J 1999; 63: 732-736. (Pubitemid 29436673)
23. 123I-15-(p-iodophenyl)-3-R,S- methylpentadecanoic acid myocardial single photon emission computed tomography in a stunned myocardium induced by coronary microvascular spasm. Ann Nucl Med 2000; 14: 303-309. (Pubitemid 30775676)
24. Kataoka K, Nohara R, Hosokawa R, Hirai T, Okuda K, Li-Guang C, et al. Myocardial lipid metabolism in compensated and advanced stages of heart failure: Evaluation by canine pacing model with BMIPP. J Nucl Med 2001; 42: 124-129. (Pubitemid 32104789)
25. 99mTc-tetrofosmin electrocardiographically gated SPECT. Ann Nucl Med 2003; 7: 541-548.
26. Sakurabayashi T, Takaesu Y, Haginoshita S, Takeda T, Aoike I, Miyazaki S, et al. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients. Am J Nephrol 1999; 19: 480-484. (Pubitemid 29397077)
27. Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Yonekura Y, Tamaki N, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996; 37: 757-761. (Pubitemid 126447786)